Program Generally. The Parties will jointly conduct the Program. It is intended that Acuitas will be responsible for the lipid chemistry and LNP formulation and characterization work, Verve will be responsible for Genome Editing Construct development and Acuitas and Verve will each undertake preclinical studies as set forth in the Workplan.
Appears in 2 contracts
Sources: Development and Option Agreement (Verve Therapeutics, Inc.), Development and Option Agreement (Verve Therapeutics, Inc.)
Program Generally. The Parties will jointly conduct the Program. It is intended that Acuitas will be responsible for the lipid chemistry and LNP formulation and characterization work, Verve CureVac will be responsible for Genome Editing mRNA Construct development and Acuitas and Verve CureVac will each undertake preclinical studies as set forth allocated in the WorkplanWork Plan.
Appears in 1 contract